The stock of Coursera Inc (COUR) has seen a -1.91% decrease in the past week, with a -3.14% drop in the past month, and a 8.13% flourish in the past quarter. The volatility ratio for the week is 5.31%, and the volatility levels for the past 30 days are at 4.08% for COUR. The simple moving average for the last 20 days is -3.72% for COUR stock, with a simple moving average of -39.60% for the last 200 days.
Is It Worth Investing in Coursera Inc (NYSE: COUR) Right Now?
The 36-month beta value for COUR is at 1.42. Analysts have varying views on the stock, with 8 analysts rating it as a “buy,” 2 rating it as “overweight,” 2 as “hold,” and 1 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for COUR is 130.44M, and currently, shorts hold a 6.74% of that float. The average trading volume for COUR on September 12, 2024 was 2.67M shares.
COUR) stock’s latest price update
Coursera Inc (NYSE: COUR)’s stock price has increased by 2.39 compared to its previous closing price of 7.53. However, the company has seen a -1.91% decrease in its stock price over the last five trading sessions. accesswire.com reported 2024-08-14 that Companies share joint commitment to leveraging technology for STEM education Accessible education on cutting-edge science and technology represents critical step toward closing workforce readiness gap CAMBRIDGE, MA and MOUNTAIN VIEW, CA / ACCESSWIRE / August 14, 2024 / Moderna, Inc. (NASDAQ:MRNA) and Coursera (NYSE:COUR) today announced a partnership to launch mRNAs as Medicines, a three-module course designed by experts at Moderna that offers a comprehensive understanding of mRNA medicines, how they work and their potential applications. mRNAs as Medicines is available for free to individuals who register as Coursera learners.
Analysts’ Opinion of COUR
Many brokerage firms have already submitted their reports for COUR stocks, with Telsey Advisory Group repeating the rating for COUR by listing it as a “Outperform.” The predicted price for COUR in the upcoming period, according to Telsey Advisory Group is $18 based on the research report published on April 30, 2024 of the current year 2024.
Goldman, on the other hand, stated in their research note that they expect to see COUR reach a price target of $14, previously predicting the price at $18. The rating they have provided for COUR stocks is “Sell” according to the report published on January 19th, 2024.
BMO Capital Markets gave a rating of “Outperform” to COUR, setting the target price at $24 in the report published on October 12th of the previous year.
COUR Trading at -2.29% from the 50-Day Moving Average
After a stumble in the market that brought COUR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -63.73% of loss for the given period.
Volatility was left at 4.08%, however, over the last 30 days, the volatility rate increased by 5.31%, as shares sank -3.99% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +9.05% upper at present.
During the last 5 trading sessions, COUR fell by -1.91%, which changed the moving average for the period of 200-days by -60.86% in comparison to the 20-day moving average, which settled at $7.99. In addition, Coursera Inc saw -60.20% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at COUR starting from Ng Andrew Y., who sale 25,000 shares at the price of $8.40 back on Aug 21 ’24. After this action, Ng Andrew Y. now owns 7,203,892 shares of Coursera Inc, valued at $210,067 using the latest closing price.
Clark Amanda, the Director of Coursera Inc, sale 1,562 shares at $8.23 during a trade that took place back on Aug 15 ’24, which means that Clark Amanda is holding 74,704 shares at $12,857 based on the most recent closing price.
Stock Fundamentals for COUR
Current profitability levels for the company are sitting at:
- -0.19 for the present operating margin
- 0.52 for the gross margin
The net margin for Coursera Inc stands at -0.14. The total capital return value is set at -0.22. Equity return is now at value -15.96, with -10.61 for asset returns.
Based on Coursera Inc (COUR), the company’s capital structure generated 0.0 points at debt to capital in total, while cash flow to debt ratio is standing at 32.82. The debt to equity ratio resting at 0.0. The interest coverage ratio of the stock is -6.52.
Currently, EBITDA for the company is -145.6 million with net debt to EBITDA at 6.51. When we switch over and look at the enterprise to sales, we see a ratio of 0.74. The receivables turnover for the company is 11.67for trailing twelve months and the total asset turnover is 0.75. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.52.
Conclusion
In conclusion, Coursera Inc (COUR) has had a bad performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
